RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nectar Lifesciences Stock

Nectar Lifesciences Equity 2024

Nectar Lifesciences Equity

10.69 B INR

Ticker

NECLIFE.NS

ISIN

INE023H01027

In 2024, Nectar Lifesciences's equity was 10.69 B INR, a -1.71% increase from the 10.88 B INR equity in the previous year.

Nectar Lifesciences Aktienanalyse

What does Nectar Lifesciences do?

Nectar Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Nectar Lifesciences's Equity

Nectar Lifesciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Nectar Lifesciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Nectar Lifesciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Nectar Lifesciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Nectar Lifesciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Nectar Lifesciences stock

What is the equity of Nectar Lifesciences this year?

Nectar Lifesciences has equity of 10.69 B INR this year.

What was the equity of Nectar Lifesciences compared to the previous year?

The equity of Nectar Lifesciences has increased/decreased by -1.71% decreased compared to the previous year.

What impact does a high equity have on investors of Nectar Lifesciences?

A high equity is advantageous for investors of Nectar Lifesciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Nectar Lifesciences?

A low equity can be a risk for investors of Nectar Lifesciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Nectar Lifesciences affect the company?

An increase in equity of Nectar Lifesciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Nectar Lifesciences affect the company?

A reduction in equity of Nectar Lifesciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Nectar Lifesciences?

Some factors that can affect the equity of Nectar Lifesciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Nectar Lifesciences so important for investors?

The equity of Nectar Lifesciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Nectar Lifesciences take to change the equity?

To change equity, Nectar Lifesciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Nectar Lifesciences pay?

Over the past 12 months, Nectar Lifesciences paid a dividend of 0.05 INR . This corresponds to a dividend yield of about 0.13 %. For the coming 12 months, Nectar Lifesciences is expected to pay a dividend of 0 INR.

What is the dividend yield of Nectar Lifesciences?

The current dividend yield of Nectar Lifesciences is 0.13 %.

When does Nectar Lifesciences pay dividends?

Nectar Lifesciences pays a quarterly dividend. This is distributed in the months of October, October, October, October.

How secure is the dividend of Nectar Lifesciences?

Nectar Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Nectar Lifesciences?

For the upcoming 12 months, dividends amounting to 0 INR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nectar Lifesciences located?

Nectar Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nectar Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nectar Lifesciences from 10/20/2020 amounting to 0.05 INR, you needed to have the stock in your portfolio before the ex-date on 9/11/2020.

When did Nectar Lifesciences pay the last dividend?

The last dividend was paid out on 10/20/2020.

What was the dividend of Nectar Lifesciences in the year 2023?

In the year 2023, Nectar Lifesciences distributed 0 INR as dividends.

In which currency does Nectar Lifesciences pay out the dividend?

The dividends of Nectar Lifesciences are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Nectar Lifesciences

Our stock analysis for Nectar Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nectar Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.